Get Premium to unlock powerful stock data
NAS:PEAR (USA)  
Pear Therapeutics Inc logo

Pear Therapeutics Inc

$ 1.57 +0.03 (+1.95%) 08:08 PM EST
P/E:
At Loss
P/B:
3.12
Market Cap:
$ 216.82M
Enterprise V:
$ 118.04M
Volume:
116.16K
Avg Vol (2M):
352.23K
Volume:
116.16K
Market Cap $:
216.82M
PE Ratio:
At Loss
Avg Vol (2-Month):
352.23K
Enterprise Value $:
118.04M
PB Ratio:
3.12
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Pear Therapeutics Inc
NAICS : 923120 SIC : 7372
200 State Street, 13th Floor, Boston, MA, USA, 02109
Description
Pear Therapeutics Inc is engaged in developing and commercializing software-based medicines, called prescription digital therapeutics. It focuses to redefine care through the widespread use of clinically validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers.
Name Current Vs Industry Vs History
Cash-To-Debt 3.56
Equity-to-Asset 0.4
Debt-to-Equity 0.56
Debt-to-EBITDA -0.33
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -1.34
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 17.5
9-Day RSI 22.71
14-Day RSI 27.7
6-1 Month Momentum % -39.03

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.24
Quick Ratio 3.24
Cash Ratio 2.96
Days Sales Outstanding 88.8
Days Payable 169.57

Dividend & Buy Back

Name Current Vs Industry Vs History

Financials (Next Earnings Date:2022-08-31 Est.)

PEAR's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:PEAR

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 6.581
EPS (TTM) ($) -0.472
Beta 0
Volatility % 0
14-Day RSI 27.7
14-Day ATR ($) 0.316106
20-Day SMA ($) 2.2545
12-1 Month Momentum % 0
52-Week Range ($) 1.53 - 14.6
Shares Outstanding (Mil) 138.1

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Pear Therapeutics Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More